KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Inventory Average (2022 - 2025)

Novavax has reported Inventory Average over the past 4 years, most recently at $12.5 million for Q4 2025.

  • Quarterly results put Inventory Average at $12.5 million for Q4 2025, up 44.11% from a year ago — trailing twelve months through Dec 2025 was $12.5 million (up 44.11% YoY), and the annual figure for FY2025 was $10.1 million, down 59.77%.
  • Inventory Average for Q4 2025 was $12.5 million at Novavax, up from $11.9 million in the prior quarter.
  • Over the last five years, Inventory Average for NVAX hit a ceiling of $181.5 million in Q2 2022 and a floor of $8.7 million in Q4 2024.
  • Median Inventory Average over the past 4 years was $28.8 million (2023), compared with a mean of $46.1 million.
  • Biggest five-year swings in Inventory Average: plummeted 84.38% in 2024 and later surged 44.11% in 2025.
  • Novavax's Inventory Average stood at $59.6 million in 2022, then fell by 6.57% to $55.6 million in 2023, then plummeted by 84.38% to $8.7 million in 2024, then surged by 44.11% to $12.5 million in 2025.
  • The last three reported values for Inventory Average were $12.5 million (Q4 2025), $11.9 million (Q3 2025), and $10.3 million (Q2 2025) per Business Quant data.